Canada Biotechnology & Medical Research

Eupraxia Pharmaceuticals Inc (EPRX)

Track

The most recent insider trading activity for Eupraxia Pharmaceuticals Inc. occurred on March 27, 2026. During March 2026, directors Simon Neil Pimstone and Joseph Stuart Freedman executed multiple buy transactions, while director Paul Geyer recorded a sale. No insider trading activity has been reported in the last three months.
Ticker: EPRX Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Eupraxia Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 27 Mar 2026
Value CA$2,564,514.06 | Price 106.98 | Shares 11,383 (-46.8%)
Buy 27 Mar 2026
Value CA$2,323,863.52 | Price 264.25 | Shares 37,090 (+46.7%)
Buy 27 Mar 2026
Value CA$18,880.00 | Price 9.44 | Shares 2,000 (+5.4%)
Buy 27 Mar 2026
Value CA$18,800.00 | Price 9.40 | Shares 2,000 (+5.7%)
Buy 27 Mar 2026
Value CA$23,475.00 | Price 9.39 | Shares 2,500 (+7.7%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-27 2026-03-27 B Purchase
2.9
Pimstone, Simon Neil

Director of Issuer

Non-Executive Director
11,383 -46.8%
106.98
CA$2,564,514 		11,383 -46.8% 106.98 CA$2,564,514
2026-03-27 2026-03-27 B Purchase
2.9
Pimstone, Simon Neil

Director of Issuer

Non-Executive Director
37,090 +46.7%
264.25
CA$2,323,864 		37,090 +46.7% 264.25 CA$2,323,864
2026-03-27 2026-03-27 B Purchase
2.9
Pimstone, Simon Neil

Director of Issuer

Non-Executive Director
32,888 -8.5%
288.46
CA$4,850,990 		32,888 -8.5% 288.46 CA$4,850,990
2026-03-27 2026-03-27 B Purchase
2.9
Pimstone, Simon Neil

Director of Issuer

Non-Executive Director
2,000 +5.7%
9.40
CA$18,800 		2,000 +5.7% 9.40 CA$18,800
2026-03-27 2026-03-27 B Purchase
2.9
Pimstone, Simon Neil

Director of Issuer

Non-Executive Director
2,500 +7.7%
9.39
CA$23,475 		2,500 +7.7% 9.39 CA$23,475
2026-03-18 2026-03-18 S Sale
3.0
Geyer, Paul

Director of Issuer

Non-Executive Director
15,000 -30.8%
10.80
CA$162,000 		15,000 -30.8% 10.80 CA$162,000
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,800 +5.1%
10.65
CA$19,169 		1,800 +5.1% 10.65 CA$19,169
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
4,200 +59.7%
10.72
CA$45,003 		4,200 +59.7% 10.72 CA$45,003
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,929 +5.2%
10.90
CA$21,026 		1,929 +5.2% 10.90 CA$21,026
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,300 +3.7%
10.83
CA$14,084 		1,300 +3.7% 10.83 CA$14,084
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,700 +0.5%
10.89
CA$18,519 		1,700 +0.5% 10.89 CA$18,519
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,800 +0.5%
10.91
CA$19,638 		1,800 +0.5% 10.91 CA$19,638
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
400 +0.1%
10.88
CA$4,352 		400 +0.1% 10.88 CA$4,352
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
3,874 +11.7%
10.17
CA$39,386 		3,874 +11.7% 10.17 CA$39,386
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,700 +0.1%
10.90
CA$18,533 		1,700 +0.1% 10.90 CA$18,533
2026-02-21 2026-02-20 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
142,858 +9.6%
7.00
US$1,000,006 		142,858 +9.6% 7.00 US$1,000,006
2026-02-21 2026-02-20 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
125,622 +9.2%
9.59
CA$1,204,715 		125,622 +9.2% 9.59 CA$1,204,715
2026-02-21 2026-02-20 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
7,037
8.59
CA$60,448 		7,037 8.59 CA$60,448
2026-02-21 2026-02-20 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
4,483 +1.4%
9.59
CA$42,992 		4,483 +1.4% 9.59 CA$42,992
2025-11-26 2025-11-24 B Purchase
3.3
Brennan, Paul Anthony

Senior Officer of Issuer

Officer
7,000 +19.2%
8.81
CA$61,660 		7,000 +19.2% 8.81 CA$61,660
Explore more

More insider trading research around Eupraxia Pharmaceuticals Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America